FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Dorothy McCabe

Research Profile

Chemicals & Drugs

Disorders

Rheumatoid Arthritis

Procedures

Phenomena

Concepts & Ideas

Anatomy

Joints
Hand

Devices

Placebos

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
George Nuki; Barry Bresnihan; Moraye B Bear; Dorothy McCabe
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Stanley Cohen; Eric Hurd; John J Cush; Michael Schiff; Michael E Weinblatt; Larry W Moreland; Joel Kremer; Moraye B Bear; William J Rich; Dorothy McCabe
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Yebin Jiang; Harry K Genant; I Watt; M Cobby; Barry Bresnihan; R Aitchison; Dorothy McCabe
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Dorothy McCabe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2002: George Nuki; Barry Bresnihan; Moraye B Bear; Dorothy McCabe
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2002;46(11):2838-46.
2002: Stanley Cohen; Eric Hurd; John J Cush; Michael Schiff; Michael E Weinblatt; Larry W Moreland; Joel Kremer; Moraye B Bear; William J Rich; Dorothy McCabe
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2002;46(3):614-24.
2000: Yebin Jiang; Harry K Genant; I Watt; M Cobby; Barry Bresnihan; R Aitchison; Dorothy McCabe
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
Arthritis and rheumatism 2000;43(5):1001-9.
1998: Barry Bresnihan; J M Alvaro-Gracia; M Cobby; Michael Doherty; Z Domljan; P Emery; George Nuki; Karel Pavelka; R Rau; Blaz Rozman; I Watt; B Williams; R Aitchison; Dorothy McCabe; P Musikic
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
Arthritis and rheumatism 1998;41(12):2196-204.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.